HIV Diagnostics Market Report

HIV Diagnostics Market Analysis By Product (Antibody Tests, Viral Identification Assays, CD4 Testing, Viral Load Testing, Early Infant Diagnosis) And Segment Forecasts To 2022

  • Published Date: Jan, 2016
  • Base Year for Estimate: 2015
  • Report ID: 978-1-68038-461-1
  • Format: Electronic (PDF)
  • Historical Data: 2013-2015
  • Number of Pages: 121

Market segmentation

  • Global HIV Diagnostics Product Outlook (Revenue, USD Million, 2012 - 2022)
    • Antibody Tests
      • HIV-1 Screening Tests
        • ELISA/EIA
        • Home Access Dried Blood Spot
        • Rapid Tests (Dot plot, Agglutination Tests)
        • HIV-1 Antibody Confirmatory Tests
          • Western Blot Test
          • Indirect Immunofluorescent Antibody Assay (IFA)
          • Line Immunoassay
          • RadioImmunoPrecipitation Assay (RIPA)
        • HIV-2 & Group O Diagnostic Tests
          • Blood Antibody Tests
          • Dried Blood Spot (DBS) Test
          • Others and (Oral, Urine)
    • Viral Identification Assays
      • P24 Antigen Test
      • Qualitative PCR Tests
      • Viral Culture
    • CD4 Testing
    • Viral Load Testing
    • Early Infant Diagnostics
  • Global HIV Diagnostics Regional Outlook (Revenue, USD Million, 2012 - 2022)
    • North America
      • The U.S.
        • U.S. HIV Diagnostics, by Product (Revenue, USD Million, 2012 - 2022)
          •   Antibody Tests
            • HIV-1 Screening Tests
              • ELISA/EIA
              • Home Access Dried Blood Spot
              • Rapid Tests (Dot plot, Agglutination Tests)
            • HIV-1 Antibody Confirmatory Tests
              • Western Blot Test
              • Indirect Immunofluorescent Antibody Assay (IFA)
              • Line Immunoassay
              • RadioImmunoPrecipitation Assay (RIPA)
            • HIV-2 & Group O Diagnostic Tests
              • Blood Antibody Tests
              • Dried Blood Spot (DBS) Test
              • Others and (Oral, Urine)
          • Viral Identification Assays
            • P24 Antigen Test
            • Qualitative PCR Tests
            • Viral Culture
          • CD4 Testing
          • Viral Load Testing
          • Early Infant Diagnostics
      • Canada
        • Canada HIV Diagnostics, by Product (Revenue, USD Million, 2012 - 2022)
          •   Antibody Tests
            • HIV-1 Screening Tests
              • ELISA/EIA
              • Home Access Dried Blood Spot
              • Rapid Tests (Dot plot, Agglutination Tests)
            • HIV-1 Antibody Confirmatory Tests
              • Western Blot Test
              • Indirect Immunofluorescent Antibody Assay (IFA)
              • Line Immunoassay
              • RadioImmunoPrecipitation Assay (RIPA)
            • HIV-2 & Group O Diagnostic Tests
              • Blood Antibody Tests
              • Dried Blood Spot (DBS) Test
              • Others and (Oral, Urine)
          • Viral Identification Assays
            • P24 Antigen Test
            • Qualitative PCR Tests
            • Viral Culture
          • CD4 Testing
          • Viral Load Testing
          • Early Infant Diagnostics
    • Europe
      • Germany
        • Germany HIV Diagnostics, by Product (Revenue, USD Million, 2012 - 2022)
          •   Antibody Tests
            • HIV-1 Screening Tests
              • ELISA/EIA
              • Home Access Dried Blood Spot
              • Rapid Tests (Dot plot, Agglutination Tests)
            • HIV-1 Antibody Confirmatory Tests
              • Western Blot Test
              • Indirect Immunofluorescent Antibody Assay (IFA)
              • Line Immunoassay
              • RadioImmunoPrecipitation Assay (RIPA)
            • HIV-2 & Group O Diagnostic Tests
              • Blood Antibody Tests
              • Dried Blood Spot (DBS) Test
              • Others and (Oral, Urine)
          • Viral Identification Assays
            • P24 Antigen Test
            • Qualitative PCR Tests
            • Viral Culture
          • CD4 Testing
          • Viral Load Testing
          • Early Infant Diagnostics
      • UK
        • UK HIV Diagnostics, by Product (Revenue, USD Million, 2012 - 2022)
          •   Antibody Tests
            • HIV-1 Screening Tests
              • ELISA/EIA
              • Home Access Dried Blood Spot
              • Rapid Tests (Dot plot, Agglutination Tests)
            • HIV-1 Antibody Confirmatory Tests
              • Western Blot Test
              • Indirect Immunofluorescent Antibody Assay (IFA)
              • Line Immunoassay
              • RadioImmunoPrecipitation Assay (RIPA)
            • HIV-2 & Group O Diagnostic Tests
              • Blood Antibody Tests
              • Dried Blood Spot (DBS) Test
              • Others and (Oral, Urine)
          • Viral Identification Assays
            • P24 Antigen Test
            • Qualitative PCR Tests
            • Viral Culture
          • CD4 Testing
          • Viral Load Testing
          • Early Infant Diagnostics
    • Asia Pacific
      • Japan
        • Japan HIV Diagnostics, by Product (Revenue, USD Million, 2012 - 2022)
          •   Antibody Tests
            • HIV-1 Screening Tests
              • ELISA/EIA
              • Home Access Dried Blood Spot
              • Rapid Tests (Dot plot, Agglutination Tests)
            • HIV-1 Antibody Confirmatory Tests
              • Western Blot Test
              • Indirect Immunofluorescent Antibody Assay (IFA)
              • Line Immunoassay
              • RadioImmunoPrecipitation Assay (RIPA)
            • HIV-2 & Group O Diagnostic Tests
              • Blood Antibody Tests
              • Dried Blood Spot (DBS) Test
              • Others and (Oral, Urine)
          • Viral Identification Assays
            • P24 Antigen Test
            • Qualitative PCR Tests
            • Viral Culture
          • CD4 Testing
          • Viral Load Testing
          • Early Infant Diagnostics
      • China
        • China HIV Diagnostics, by Product (Revenue, USD Million, 2012 - 2022)
          •   Antibody Tests
            • HIV-1 Screening Tests
              • ELISA/EIA
              • Home Access Dried Blood Spot
              • Rapid Tests (Dot plot, Agglutination Tests)
            • HIV-1 Antibody Confirmatory Tests
              • Western Blot Test
              • Indirect Immunofluorescent Antibody Assay (IFA)
              • Line Immunoassay
              • RadioImmunoPrecipitation Assay (RIPA)
            • HIV-2 & Group O Diagnostic Tests
              • Blood Antibody Tests
              • Dried Blood Spot (DBS) Test
              • Others and (Oral, Urine)
          • Viral Identification Assays
            • P24 Antigen Test
            • Qualitative PCR Tests
            • Viral Culture
          • CD4 Testing
          • Viral Load Testing
          • Early Infant Diagnostics
    • Latin America
      • Brazil
        • Brazil HIV Diagnostics, by Product (Revenue, USD Million, 2012 - 2022)
          •   Antibody Tests
            • HIV-1 Screening Tests
              • ELISA/EIA
              • Home Access Dried Blood Spot
              • Rapid Tests (Dot plot, Agglutination Tests)
            • HIV-1 Antibody Confirmatory Tests
              • Western Blot Test
              • Indirect Immunofluorescent Antibody Assay (IFA)
              • Line Immunoassay
              • RadioImmunoPrecipitation Assay (RIPA)
            • HIV-2 & Group O Diagnostic Tests
              • Blood Antibody Tests
              • Dried Blood Spot (DBS) Test
              • Others and (Oral, Urine)
          • Viral Identification Assays
            • P24 Antigen Test
            • Qualitative PCR Tests
            • Viral Culture
          • CD4 Testing
          • Viral Load Testing
          • Early Infant Diagnostics
    • MEA
      • South Africa
        • South Africa HIV Diagnostics, by Product (Revenue, USD Million, 2012 - 2022)
          •   Antibody Tests
            • HIV-1 Screening Tests
              • ELISA/EIA
              • Home Access Dried Blood Spot
              • Rapid Tests (Dot plot, Agglutination Tests)
            • HIV-1 Antibody Confirmatory Tests
              • Western Blot Test
              • Indirect Immunofluorescent Antibody Assay (IFA)
              • Line Immunoassay
              • RadioImmunoPrecipitation Assay (RIPA)
            • HIV-2 & Group O Diagnostic Tests
              • Blood Antibody Tests
              • Dried Blood Spot (DBS) Test
              • Others and (Oral, Urine)
          • Viral Identification Assays
            • P24 Antigen Test
            • Qualitative PCR Tests
            • Viral Culture
          • CD4 Testing
          • Viral Load Testing
          • Early Infant Diagnostics

Report Content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Application Segments Prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments 

Quantitative Analysis

  • Market size, estimates, and forecast from 2012 to 2022
  • Revenue estimates for product up to 2022
  • Regional market size and forecast for product up to 2022
  • Revenue estimates for product segments up to 2022
  • Regional market size and forecast for segments up to 2022
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.